Raloxifene trial in postmenopausal woman with treatment-resistant schizophrenia

Archives of Women's Mental Health

Volumn 18, Issue 5, 2015, Pages 741-742

  Tharoor, Hema ^a   Goyal, Aparna ^a  

^a SCHIZOPHRENIA RESEARCH FOUNDATION   (India)

Author keywords

Postmenopausal; Raloxifene; SERM; Treatment resistant schizophrenia

Indexed keywords

AMISULPRIDE; CLOZAPINE; ORAL ANTIDIABETIC AGENT; QUETIAPINE; RALOXIFENE; RISPERIDONE; TRIHEXYPHENIDYL; NEUROLEPTIC AGENT; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADD ON THERAPY; ADULT; ARTICLE; AUDITORY HALLUCINATION; CASE REPORT; CEREBROVASCULAR ACCIDENT; CONFUSION; DEEP VEIN THROMBOSIS; DELUSION; DIABETES MELLITUS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MEDICAL HISTORY; MIDDLE AGED; PARANOID SCHIZOPHRENIA; POSITIVE AND NEGATIVE SYNDROME SCALE; POSTMENOPAUSE; PRIORITY JOURNAL; SCHIZOPHRENIA; SEDATION; TREATMENT DURATION; TREATMENT RESISTANT SCHIZOPHRENIA; DOSE RESPONSE; DRUG COMBINATION; DRUG EFFECTS; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; RALOXIFENE HYDROCHLORIDE; SCHIZOPHRENIA; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TREATMENT OUTCOME;

EID: 84941419583     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-015-0545-9     Document Type: Article

References (9)

1. Akhondzadeh S, Nejatisafa AA, Amini H et al (2003) Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry 27(6):1007–1012
2. Kianimehr G, Fatehi F, Hashempoor S et al (2014) Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial. DARU Journal of Pharmaceutical Sciences; 22(1):55. doi:10.1186/2008-2231-22-55
3. Kulkarni J, Riedel A, De Castella A et al (2001) Estrogen—a potential treatment for schizophrenia. Schizophr Res 48(1):137–144
4. Kulkarni J, De Castella A, Fitzgerald PB, Gurvich CT et al (2008) Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65(8):955–60
5. Kulkarni J, Gurvich C, Lee SJ et al (2010) Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Psycho neuroendocrinology 35(8):1142–1147
6. Kulkarni J, Gavrilidis E, Worsley R, Hayes E (2012) Role of estrogen treatment in the management of schizophrenia. CNS Drugs 26(7):549–557
7. Kulkarni J, Gavrilidis E, Wang W et al (2015) Estradiol for treatment-resistant schizophrenia: a large-scale randomized-controlled trial in women of childbearing age. Mol Psychiatry 20(6):695–702
8. Lindamer LA, BuseDC LJB et al (2001) Hormone replacement therapy in postmenopausal women with schizophrenia: positive effect on negative symptoms? Biol Psychiatry 49(1):47–51
9. Usall J, Huerta-Ramos IR et al (2011) Raloxifene as adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, and placebo-controlled trial. J Clin Psychiatry 72(11):1552–1557